Agf Investments Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Agf Investments Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$127.18 - $173.91 $366,532 - $501,208	-2,882 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$159.56 - $209.29 $84,407 - $110,714	-529 Reduced 15.51%	2,882 $489,000
Q3 2021 Nov 10, 2021	BUY	$169.75 - $207.73 $44,135 - $54,009	260 Added 8.25%	3,411 $644,000
Q2 2021 Aug 10, 2021	BUY	$128.63 - $176.89 $261,762 - $359,971	2,035 Added 182.35%	3,151 $534,000
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $55,932 - $77,479	-441 Reduced 28.32%	1,116 $158,000
Q4 2020 Feb 08, 2021	SELL	$122.97 - $147.0 $451,299 - $539,490	-3,670 Reduced 70.21%	1,557 $202,000
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $353,995 - $483,396	2,921 Added 126.67%	5,227 $761,000
Q2 2020 Aug 11, 2020	BUY	$104.21 - $156.44 $239,474 - $359,499	2,298 Added 28725.0%	2,306 $342,000
Q1 2020 May 08, 2020	BUY	$93.12 - $133.99 $744 - $1,071	8 New	8 $1,000

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.